Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

por Penson, Richard T., Valencia, Ricardo Villalobos, Cibula, David, Colombo, Nicoletta, Leath, Charles A., Bidziński, Mariusz, Kim, Jae-Weon, Nam, Joo Hyun, Madry, Radoslaw, Hernández, Carlos, Mora, Paulo A.R., Ryu, Sang Young, Milenkova, Tsveta, Lowe, Elizabeth S., Barker, Laura, Scambia, Giovanni
Publicado 2020

A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer

por Kim, Tae Won, Elme, Anneli, Kusic, Zvonko, Park, Joon Oh, Udrea, Anghel Adrian, Kim, Sun Young, Ahn, Joong Bae, Valencia, Ricardo Villalobos, Krishnan, Srinivasan, Bilic, Ante, Manojlovic, Nebojsa, Dong, Jun, Guan, Xuesong, Lofton-Day, Catherine, Jung, A Scott, Vrdoljak, Eduard
Publicado 2016